Exact Mass: 1062.5974

Yamogenintetroside B

C52H86O22 (1062.561)

Methylprotodioscin is a steroid saponin. Methylprotodioscin is a natural product found in Dracaena draco, Smilax menispermoidea, and other organisms with data available. Methylprotodioscin is found in herbs and spices. Methylprotodioscin is isolated from seeds of Trigonella caerulea (sweet trefoil) and Asparagus officinalis (asparagus). Methyl protodioscin(NSC-698790) is a furostanol bisglycoside with antitumor properties; shows to reduce proliferation, cause cell cycle arrest. IC50 value: Target: in vitro: MPD showed growth inhibitory effects in A549 cells in a dose- and time-dependent manner. The significant G2/M cell cycle arrest and apoptotic effect were also seen in A549 cells treated with MPD. MPD-induced apoptosis was accompanied by a significant reduction of mitochondrial membrane potential, release of mitochondrial cytochrome c to cytosol, activation of caspase-3, downregulation of Bcl-2, p-Bad, and upregulation of Bax [1]. In THP-1 macrophages, MPD increases levels of ABCA1 mRNA and protein in dose- and time-dependent manners, and apoA-1-mediated cholesterol efflux. MPD also decreases the gene expressions of HMGCR, FAS and ACC for cholesterol and fatty acid synthesis [2]. Methyl protodioscin(NSC-698790) is a furostanol bisglycoside with antitumor properties; shows to reduce proliferation, cause cell cycle arrest. IC50 value: Target: in vitro: MPD showed growth inhibitory effects in A549 cells in a dose- and time-dependent manner. The significant G2/M cell cycle arrest and apoptotic effect were also seen in A549 cells treated with MPD. MPD-induced apoptosis was accompanied by a significant reduction of mitochondrial membrane potential, release of mitochondrial cytochrome c to cytosol, activation of caspase-3, downregulation of Bcl-2, p-Bad, and upregulation of Bax [1]. In THP-1 macrophages, MPD increases levels of ABCA1 mRNA and protein in dose- and time-dependent manners, and apoA-1-mediated cholesterol efflux. MPD also decreases the gene expressions of HMGCR, FAS and ACC for cholesterol and fatty acid synthesis [2].

Hoduloside IX

C52H86O22 (1062.561)

Hoduloside IX is a constituent of Hovenia dulcis (raisin tree).

Cellotetraosylsitosterol

C53H90O21 (1062.5974)

Cellotetraosylsitosterol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cellotetraosylsitosterol can be found in rice, which makes cellotetraosylsitosterol a potential biomarker for the consumption of this food product.

Ardisianoside G

C52H86O22 (1062.561)

Micropeptin 88-N

C54H78N8O14 (1062.5637)

mycaloside I

C52H86O22 (1062.561)

Protodioscin 22-methyl ether

C52H86O22 (1062.561)

Smilax saponin B

C52H86O22 (1062.561)

Methyl protodioscin(NSC-698790) is a furostanol bisglycoside with antitumor properties; shows to reduce proliferation, cause cell cycle arrest. IC50 value: Target: in vitro: MPD showed growth inhibitory effects in A549 cells in a dose- and time-dependent manner. The significant G2/M cell cycle arrest and apoptotic effect were also seen in A549 cells treated with MPD. MPD-induced apoptosis was accompanied by a significant reduction of mitochondrial membrane potential, release of mitochondrial cytochrome c to cytosol, activation of caspase-3, downregulation of Bcl-2, p-Bad, and upregulation of Bax [1]. In THP-1 macrophages, MPD increases levels of ABCA1 mRNA and protein in dose- and time-dependent manners, and apoA-1-mediated cholesterol efflux. MPD also decreases the gene expressions of HMGCR, FAS and ACC for cholesterol and fatty acid synthesis [2]. Methyl protodioscin(NSC-698790) is a furostanol bisglycoside with antitumor properties; shows to reduce proliferation, cause cell cycle arrest. IC50 value: Target: in vitro: MPD showed growth inhibitory effects in A549 cells in a dose- and time-dependent manner. The significant G2/M cell cycle arrest and apoptotic effect were also seen in A549 cells treated with MPD. MPD-induced apoptosis was accompanied by a significant reduction of mitochondrial membrane potential, release of mitochondrial cytochrome c to cytosol, activation of caspase-3, downregulation of Bcl-2, p-Bad, and upregulation of Bax [1]. In THP-1 macrophages, MPD increases levels of ABCA1 mRNA and protein in dose- and time-dependent manners, and apoA-1-mediated cholesterol efflux. MPD also decreases the gene expressions of HMGCR, FAS and ACC for cholesterol and fatty acid synthesis [2].

(3beta,20S)-3,20,21-trihydroxydammar-24-ene 3-O-{[alpha-L-rhamnopyranosyl-(1-2)]-[beta-D-xylopyranosyl-(1-3)]-beta-D-glucopyranosyl}-21-O-beta-D-glucopyranoside|3beta,20S,21-trihydroxydammar-24-ene 3-O-{[alpha-L-rhamnopyranosyl(1->2)][beta-D-xylopyranosyl(1->3)]-beta-D-glucopyranosyl}-21-O-beta-D-glucopyranoside

C53H90O21 (1062.5974)

Gypenoside XXXV

C52H86O22 (1062.561)

Pregnane glycoside OI

C56H86O19 (1062.5763)

Cellotetraosylsitosterol

C53H90O21 (1062.5974)

anagallosaponin VII

C52H86O22 (1062.561)

C52H86O22

C52H86O22 (1062.561)

Gynosaponin R

C53H90O21 (1062.5974)

3beta,20S,21-trihydroxy-25-methoxydammar-23(E)-ene 3-O-alpha-L-rhamnopyranosyl(1->2)-[beta-D-xylopyranosyl(1->3)]-beta-D-glucopyranosyl-21-O-beta-D-xylopyranoside

C53H90O21 (1062.5974)

19-oxo-3beta,20S,21,24S-tetrahydroxydammar-25-ene 3-O-{[alpha-L-rhamnopyranosyl(1->2)][beta-D-xylopyranosyl(1->3)]-alpha-L-arabinopyranosyl}-21-O-beta-D-glucopyranoside

C52H86O22 (1062.561)

Protodioscin

C52H86O22 (1062.561)

luperoside E

C53H90O21 (1062.5974)

micropeptin LH1062

C53H78N10O13 (1062.575)

3beta-O-(beta-D-xylopyranosyl-(1?2)-beta-D-glucopyranosyl-(1?4)-[beta-D-glucopyranosyl-(1?2)]-alpha-L-arabinopyranosyl)-camelliagenin A

C52H86O22 (1062.561)

3-O-{beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-alpha-L-arabinopyranosyl}-3beta,16beta-12-oleanene-3,16,23,28-tetrol|heterogenoside D

C52H86O22 (1062.561)

S-5

C52H86O22 (1062.561)

3-O-alpha-L-rhamnopyranosyl-(1->2)-O-[alpha-L-rhamnopyranosyl-(1->4)]-beta-D-glucopyranosyl-22S,25R-furost-5-ene-16alpha-methoxy-3beta,26-diol 26-O-beta-D-glucopyranoside|solaviaside B

C52H86O22 (1062.561)

anagalligenin B 3-O-{beta-D-xylopyranosyl(1?2)-beta-D-glucopyranosyl(1?4)[beta-D-glucopyranosyl (1?2)]-alpha-L-arabinopyranoside}|anagallisin C|anagalloside B|desgluconagalloside B

C52H86O22 (1062.561)

ardisicrenoside B

C52H86O22 (1062.561)

(3beta,22R,25R)-26-(beta-D-glucopyranosyloxy)-22-methoxyfurost-5-en-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->2)-[6-deoxy-alpha-L-mannopyranosyl-(1->3)]-beta-D-glucopyranoside|Methyl proto-taccaoside

C52H86O22 (1062.561)

Adscendoside A

C52H86O22 (1062.561)

3beta,20S,21-trihydroxydammar-24-ene 3-O-{[alpha-L-rhamnopyranosyl(1->2)][beta-D-glucopyranosyl(1->3)]-alpha-L-arabinopyranosyl}-21-O-beta-D-glucopyranoside

C53H90O21 (1062.5974)

3-O-[alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranosyl-(1->2)-beta-D-xylopyranosyl]-6-O-beta-D-glucopyranosyl-3beta,6alpha,16beta,24alpha-tetrahydroxy-20(R),25-epoxycycloartane|3-O-[alpha-L-rhamnopyranosyl-(1->2)-O-alpha-L-arabinopyranosyl-(1->2)-O-beta-D-xylopyranosyl]-6-O-beta-D-glucopyranosyl-3beta,6alpha,16beta,24alpha-tetrahydroxy-20(R),25-epoxycycloartane

C52H86O22 (1062.561)

C52H86O22_alpha-L-Arabinopyranoside, (3beta,5xi,9xi,16alpha)-13,28-epoxy-16,23-dihydroxyoleanan-3-yl O-beta-D-glucopyranosyl-(1->2)-O-[O-beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)]

C52H86O22 (1062.561)

methyl protodioscin

C52H86O22 (1062.561)

Methyl protodioscin(NSC-698790) is a furostanol bisglycoside with antitumor properties; shows to reduce proliferation, cause cell cycle arrest. IC50 value: Target: in vitro: MPD showed growth inhibitory effects in A549 cells in a dose- and time-dependent manner. The significant G2/M cell cycle arrest and apoptotic effect were also seen in A549 cells treated with MPD. MPD-induced apoptosis was accompanied by a significant reduction of mitochondrial membrane potential, release of mitochondrial cytochrome c to cytosol, activation of caspase-3, downregulation of Bcl-2, p-Bad, and upregulation of Bax [1]. In THP-1 macrophages, MPD increases levels of ABCA1 mRNA and protein in dose- and time-dependent manners, and apoA-1-mediated cholesterol efflux. MPD also decreases the gene expressions of HMGCR, FAS and ACC for cholesterol and fatty acid synthesis [2]. Methyl protodioscin(NSC-698790) is a furostanol bisglycoside with antitumor properties; shows to reduce proliferation, cause cell cycle arrest. IC50 value: Target: in vitro: MPD showed growth inhibitory effects in A549 cells in a dose- and time-dependent manner. The significant G2/M cell cycle arrest and apoptotic effect were also seen in A549 cells treated with MPD. MPD-induced apoptosis was accompanied by a significant reduction of mitochondrial membrane potential, release of mitochondrial cytochrome c to cytosol, activation of caspase-3, downregulation of Bcl-2, p-Bad, and upregulation of Bax [1]. In THP-1 macrophages, MPD increases levels of ABCA1 mRNA and protein in dose- and time-dependent manners, and apoA-1-mediated cholesterol efflux. MPD also decreases the gene expressions of HMGCR, FAS and ACC for cholesterol and fatty acid synthesis [2].

Gypenoside S4

C52H86O22 (1062.561)

Hoduloside IX

C52H86O22 (1062.561)

MPD cpd

C52H86O22 (1062.561)

Methylprotodioscin is a steroid saponin. Methylprotodioscin is a natural product found in Dracaena draco, Smilax menispermoidea, and other organisms with data available. Methyl protodioscin(NSC-698790) is a furostanol bisglycoside with antitumor properties; shows to reduce proliferation, cause cell cycle arrest. IC50 value: Target: in vitro: MPD showed growth inhibitory effects in A549 cells in a dose- and time-dependent manner. The significant G2/M cell cycle arrest and apoptotic effect were also seen in A549 cells treated with MPD. MPD-induced apoptosis was accompanied by a significant reduction of mitochondrial membrane potential, release of mitochondrial cytochrome c to cytosol, activation of caspase-3, downregulation of Bcl-2, p-Bad, and upregulation of Bax [1]. In THP-1 macrophages, MPD increases levels of ABCA1 mRNA and protein in dose- and time-dependent manners, and apoA-1-mediated cholesterol efflux. MPD also decreases the gene expressions of HMGCR, FAS and ACC for cholesterol and fatty acid synthesis [2]. Methyl protodioscin(NSC-698790) is a furostanol bisglycoside with antitumor properties; shows to reduce proliferation, cause cell cycle arrest. IC50 value: Target: in vitro: MPD showed growth inhibitory effects in A549 cells in a dose- and time-dependent manner. The significant G2/M cell cycle arrest and apoptotic effect were also seen in A549 cells treated with MPD. MPD-induced apoptosis was accompanied by a significant reduction of mitochondrial membrane potential, release of mitochondrial cytochrome c to cytosol, activation of caspase-3, downregulation of Bcl-2, p-Bad, and upregulation of Bax [1]. In THP-1 macrophages, MPD increases levels of ABCA1 mRNA and protein in dose- and time-dependent manners, and apoA-1-mediated cholesterol efflux. MPD also decreases the gene expressions of HMGCR, FAS and ACC for cholesterol and fatty acid synthesis [2].

MLCL 45:5

C54H96O16P2 (1062.6173)

PIM1 39:4

C54H95O18P (1062.6256)

(2s,3r,4s,5r,6r)-2-{[(2r,3r,4r,5r,6r)-6-{[(1r,3r,3ar,5as,7s,9as,9br,11ar)-3-hydroxy-1-[(2r,5e)-7-hydroxy-5-isopropylhept-5-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-{[(2s,3s,4r,5r)-4,5-dihydroxy-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(2r,3r,4s,5s,6r)-2-[(2s)-4-[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-16-{[(2r,3r,4r,5s,6r)-3,4-dihydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

2-{4-[16-({3,4-dihydroxy-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl}oxy)-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(2r,3r,4s,5s,6r)-2-[(2s)-4-[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-16-{[(2r,3r,4s,5s,6r)-4-hydroxy-6-(hydroxymethyl)-3,5-bis({[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

2-{4-[(1r,2r,4r,6r,8s,9s,12r,13r)-16-{[(2s)-4-hydroxy-6-(hydroxymethyl)-3,5-bis({[(2r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(1s,3as,3br,5ar,7s,9ar,9br,11ar)-7-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-1-[(2s,4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-3b,6,6,9a-tetramethyl-3a-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)-dodecahydrocyclopenta[a]phenanthren-2-one

C52H86O22 (1062.561)

2-{[4-hydroxy-2-(hydroxymethyl)-6-{[4-methoxy-7,9,13-trimethyl-6-(3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxy}-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C52H86O22 (1062.561)

(10r,12s)-10,12-dimethyl-n-[(3s,6s,9s,11r,15s,18r,20r,21r,24s,25s,26s)-5,8,11,17,20,21,23,25-octahydroxy-6-[(2r)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[(1r)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-15-[(1r)-1-hydroxyethyl]-26-methyl-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosa-4,7,16,22-tetraen-18-yl]tetradecanimidic acid

C51H82N8O16 (1062.5848)

(2s,3r,4r,5r,6s)-2-{[(2r,3s,4s,5r,6r)-4-hydroxy-2-(hydroxymethyl)-6-{[(1s,2s,4s,6s,7s,8r,9s,12s,13r,16s)-4-methoxy-7,9,13-trimethyl-6-[(3r)-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxy}-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C52H86O22 (1062.561)

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4s,5r,6r)-2-{[(3s,4s,5r,6s)-6-{[(1s,2r,4s,5r,8r,10s,13s,14r,17s,18r,20s)-2,20-dihydroxy-4,5,9,9,13,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]oxy}-4-hydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C52H86O22 (1062.561)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-2-{[(1s,2r,4s,5r,8r,9r,10s,13r,14r,17s,18r)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

19-oxo-3β,20s,21,24s-tetrahydroxydammar-25-ene 3-o-{[α-l-rhamnopyranosyl(1→2)][β-d-xylopyranosyl(1→3)]-α-l-arabinopyranosyl}-21-o-β-d-glucopyranoside

C52H86O22 (1062.561)

{"Ingredient_id": "HBIN002207","Ingredient_name": "19-oxo-3\u03b2,20s,21,24s-tetrahydroxydammar-25-ene 3-o-{[\u03b1-l-rhamnopyranosyl(1\u21922)][\u03b2-d-xylopyranosyl(1\u21923)]-\u03b1-l-arabinopyranosyl}-21-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C52H86O22","Ingredient_Smile": "CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C(CCC6(C5(CCC4C3(C)C)C)C)C(CCC(C(=C)C)O)(COC7C(C(C(C(O7)CO)O)O)O)O)C=O)O)OC8C(C(C(CO8)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16417","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

22-o-methylprotodioscin

C52H86O22 (1062.561)

{"Ingredient_id": "HBIN003749","Ingredient_name": "22-o-methylprotodioscin","Alias": "NA","Ingredient_formula": "C52H86O22","Ingredient_Smile": "CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)C)O)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)OC1(CCC(C)COC9C(C(C(C(O9)CO)O)O)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14690","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3β,20s,21-trihydroxydammar-24-ene 3-o-{[α-l-rhamnopyranosyl(1→2)][β-d-xylopyranosyl(1→3)]-β-d-glucopyranosyl}-21-o-β-d-glu-copyranoside

C53H90O21 (1062.5974)

{"Ingredient_id": "HBIN008054","Ingredient_name": "3\u03b2,20s,21-trihydroxydammar-24-ene 3-o-{[\u03b1-l-rhamnopyranosyl(1\u21922)][\u03b2-d-xylopyranosyl(1\u21923)]-\u03b2-d-glucopyranosyl}-21-o-\u03b2-d-glu-copyranoside","Alias": "NA","Ingredient_formula": "C53H90O21","Ingredient_Smile": "CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CCC4(C5CCC6C(CCC6(C5(CCC4C3(C)C)C)C)C(CCC=C(C)C)(COC7C(C(C(C(O7)CO)O)O)O)O)C)CO)O)OC8C(C(C(CO8)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21686","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

ardisianoside G

C52H86O22 (1062.561)

{"Ingredient_id": "HBIN016655","Ingredient_name": "ardisianoside G","Alias": "NA","Ingredient_formula": "C52H86O22","Ingredient_Smile": "CC1C(C(C(C(O1)OC2C(C(C(OC2OC3COC(C(C3O)OC4C(C(C(C(O4)CO)O)O)O)OC5CCC6(C(C5(C)C)CCC7(C6CCC89C7(CC(C1(C8CC(CC1)(C)O)CO9)O)C)C)C)CO)O)O)O)O)O","Ingredient_weight": "1063.23","OB_score": "5.618404458","CAS_id": "932018-33-2","SymMap_id": "SMIT11987","TCMID_id": "NA","TCMSP_id": "MOL011030","TCM_ID_id": "NA","PubChem_id": "16109776","DrugBank_id": "NA"}

ardisianoside G_qt

C52H86O22 (1062.561)

{"Ingredient_id": "HBIN016656","Ingredient_name": "ardisianoside G_qt","Alias": "NA","Ingredient_formula": "C52H86O22","Ingredient_Smile": "NA","Ingredient_weight": "1063.23","OB_score": "16.96563034","CAS_id": "932018-33-2","SymMap_id": "SMIT11988","TCMID_id": "NA","TCMSP_id": "MOL011031","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

ardisicrenoside B

C52H86O22 (1062.561)

{"Ingredient_id": "HBIN016672","Ingredient_name": "ardisicrenoside B","Alias": "NA","Ingredient_formula": "C52H86O22","Ingredient_Smile": "CC1(C2CCC3(C(C2(CCC1OC4C(C(C(CO4)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(CO6)O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)C)CCC89C3(CC(C1(C8CC(CC1)(C)CO)CO9)O)C)C)C","Ingredient_weight": "1063.2 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41088","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10373894","DrugBank_id": "NA"}

n-(1-{[2-benzyl-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-5-[(4-hydroxyphenyl)methyl]-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-4-methoxy-4-oxobutyl)octanimidic acid

C53H78N10O13 (1062.575)

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4s,5s)-2-{[(2s,3r,4s,5r)-4,5-dihydroxy-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-14-hydroxy-15-[(2r,5s)-5-hydroxy-2,6,6-trimethyloxan-2-yl]-7,7,12,16-tetramethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxyoxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C52H86O22 (1062.561)

(2s)-4-{[(2s,5s,8s,11r,15s,18s,21r)-5-benzyl-8-[(2s)-butan-2-yl]-6,13,16,21-tetrahydroxy-15-[(4-hydroxyphenyl)methyl]-2-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-2-{[(2s)-1-hydroxy-2-[(1-hydroxybutylidene)amino]-4-methylpentylidene]amino}butanoic acid

C54H78N8O14 (1062.5637)

2-[(6-{[6-({2,22-dihydroxy-4,5,9,9,13,20,20-heptamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl}oxy)-4,5-dihydroxyoxan-3-yl]oxy}-4-hydroxy-2-(hydroxymethyl)-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

2-[(5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxy-2-{[8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

2-({4-[(4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-5-hydroxy-6-{[3-hydroxy-1-(7-hydroxy-5-isopropylhept-5-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-2-(hydroxymethyl)oxan-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(2s,3r,4s,5s,6r)-2-{[(2r,3s,4s,5r,6r)-6-{[(3s,4r,5r,6s)-6-{[(1s,2r,4s,5r,8r,10s,13r,14r,17s,18s,22s)-2,22-dihydroxy-4,5,9,9,13,20,20-heptamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]oxy}-4,5-dihydroxyoxan-3-yl]oxy}-4-hydroxy-2-(hydroxymethyl)-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(2r,3r,4s,5s,6r)-2-[(2s)-4-[(1s,2s,4s,7s,8r,9s,12s,13r,16s)-16-{[(2r,3r,4s,5s,6r)-4-hydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-5-{[(3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(2r)-4-{[(2s,5s,8s,11s,12s,18s)-5-benzyl-8-[(2s)-butan-2-yl]-6,13,16,21-tetrahydroxy-2-isopropyl-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-2-{[(2s)-1-hydroxy-2-[(1-hydroxybutylidene)amino]-3-(4-hydroxyphenyl)propylidene]amino}butanoic acid

C54H78N8O14 (1062.5637)

n-{15,25-dibenzyl-11,14,17,27-tetrahydroxy-22-[(4-hydroxyphenyl)methyl]-9-isopropyl-19,23-dimethyl-12-(2-methylpropyl)-2,8,21,24-tetraoxo-20-oxa-1,7,10,13,16,23,26-heptaazatricyclo[26.3.0.0³,⁷]hentriaconta-10,13,16,26-tetraen-18-yl}-3-methylbutanimidic acid

C58H78N8O11 (1062.579)

(2s,3s,4r,5r,6s)-2-[(2r)-4-[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-16-{[(2s,3r,4s,5s,6r)-4-hydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

2-[4-(16-{[5-hydroxy-6-(hydroxymethyl)-3,4-bis[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl)-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

7-({4,5-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-1-[(4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-3b,6,6,9a-tetramethyl-3a-{[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]methyl}-dodecahydrocyclopenta[a]phenanthren-2-one

C52H86O22 (1062.561)

(2s,3r,4r,5r,6s)-2-{[(2s,3s,4s,5r,6r)-2-[(1r,3ar,5ar,6s,7r,9as,11ar)-6-hydroxy-1-[(2r,4s)-4-hydroxy-6-methylheptan-2-yl]-6-(hydroxymethyl)-3a,9a,11a-trimethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-{[(2s,3r,4r,5s,6s)-3,5-dihydroxy-6-methyl-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-6-methyloxane-3,4,5-triol

C53H90O21 (1062.5974)

1-(2,5-dihydroxy-6-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept-6-en-2-yl)-7-({5-hydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-3a,3b,6,6-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C52H86O22 (1062.561)

n-[(3s,9s,12s,15s,18s,19s,22s,25s,28s)-15,25-dibenzyl-11,14,17,27-tetrahydroxy-22-[(4-hydroxyphenyl)methyl]-9-isopropyl-19,23-dimethyl-12-(2-methylpropyl)-2,8,21,24-tetraoxo-20-oxa-1,7,10,13,16,23,26-heptaazatricyclo[26.3.0.0³,⁷]hentriaconta-10,13,16,26-tetraen-18-yl]-3-methylbutanimidic acid

C58H78N8O11 (1062.579)

(2r,3r,4s,5s,6r)-2-{[(2s)-2-[(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-7-{[(2r,3r,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-hydroxy-6-methylhept-5-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C53H90O21 (1062.5974)

(2r,3r,4s,5s,6r)-2-[(2r)-4-[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-16-{[(2r,3r,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3,4-bis({[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4s,5s,6r)-2-{[(3s,4s,5r,6s)-6-{[(1s,2r,4s,5r,8r,10s,13r,14r,17s,18r,20s)-2,20-dihydroxy-4,5,9,9,13,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]oxy}-4-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C52H86O22 (1062.561)

(2s,3r,4r,5r,6s)-2-{[(2r,3r,4s,5r,6r)-2-{[(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s,4e)-2-hydroxy-6-methoxy-6-methyl-1-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-4-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C53H90O21 (1062.5974)

4-{[5-benzyl-6,13,16,21-tetrahydroxy-2-isopropyl-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-8-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-2-({1-hydroxy-2-[(1-hydroxybutylidene)amino]-3-(4-hydroxyphenyl)propylidene}amino)butanoic acid

C54H78N8O14 (1062.5637)

(2s,3r,4r,5r,6s)-2-{[(2r,3s,4s,5r,6r)-4-hydroxy-6-{[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-6-hydroxy-7,9,13-trimethyl-6-[(4r)-4-methyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentyl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxy}-2-(hydroxymethyl)-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C52H86O22 (1062.561)

(2s,3s,4r,5r,6s)-2-[(2s)-4-[(1s,2s,4s,6r,7s,8r,9r,12s,13s,16r)-16-{[(2s,3s,4r,5r,6s)-4-hydroxy-6-(hydroxymethyl)-3,5-bis({[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

2-({2-[(4,5-dihydroxy-2-{[2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]oxy}oxan-3-yl)oxy]-3-hydroxy-6-(hydroxymethyl)-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-4-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

4-{[(2s,5s,8s,11r,12s,15s,21r)-5-benzyl-8-[(2s)-butan-2-yl]-6,13,16,21-tetrahydroxy-2-isopropyl-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-2-{[(2s)-1-hydroxy-2-[(1-hydroxybutylidene)amino]-3-(4-hydroxyphenyl)propylidene]amino}butanoic acid

C54H78N8O14 (1062.5637)

(2s,3r,4s,5s,6r)-2-{[(2s)-2-[(1s,3ar,3br,4s,5ar,7s,9as,9br,11ar)-7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-({[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-3,4,5-triol

C53H90O21 (1062.5974)

2-[(5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxy-2-{[2-hydroxy-20-(hydroxymethyl)-4,5,9,9,13,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]oxy}oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(2s)-4-{[(2s,5s,8s,11r,12s,15s,18s,21r)-5-benzyl-8-[(2s)-butan-2-yl]-6,13,16,21-tetrahydroxy-15-[(4-hydroxyphenyl)methyl]-2-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-2-{[(2s)-1-hydroxy-2-[(1-hydroxybutylidene)amino]-4-methylpentylidene]amino}butanoic acid

C54H78N8O14 (1062.5637)

(1s,3ar,3bs,7s,9ar,9br,11r,11as)-7-{[(2r,4s,5r,6r)-5-{[(2s,4s,5r,6r)-5-{[(2s,4s,5r,6r)-5-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-3a,3b-dihydroxy-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl benzoate

C56H86O19 (1062.5763)

(2r,3r,4s,5s,6r)-2-[(2r)-4-[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-16-{[(2r,4s,5s,6r)-4-hydroxy-6-(hydroxymethyl)-3,5-bis({[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4r,5r,6r)-2-{[(2s,3r,4s,5r)-4,5-dihydroxy-2-{[(1s,2r,4s,5r,8r,9r,10s,13r,14r,17s,18r)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]oxy}oxan-3-yl]oxy}-3-hydroxy-6-(hydroxymethyl)-5-{[(2s,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

2-({5-hydroxy-2-[(1-{2-hydroxy-6-methoxy-6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-4-en-2-yl}-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl)oxy]-6-(hydroxymethyl)-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-3-yl}oxy)-6-methyloxane-3,4,5-triol

C53H90O21 (1062.5974)

(2r,3s,5s)-2-[4-(16-{[(2r,3s,5r)-4-hydroxy-6-(hydroxymethyl)-3,5-bis({[(3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl)-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(2s,3r,4s,5s,6r)-2-{[2-(7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-11-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl)-6-methylhept-5-en-2-yl]oxy}-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C53H90O21 (1062.5974)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s)-2-{[(3s,4r,4ar,6ar,6bs,8r,8as,12as,14ar,14br)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxyoxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

2-{[2-hydroxy-2-(7-{[5-hydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl)-6-methylhept-5-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C53H90O21 (1062.5974)

7-({4,5-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-1-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-3b,6,6,9a-tetramethyl-3a-{[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]methyl}-dodecahydrocyclopenta[a]phenanthren-2-one

C52H86O22 (1062.561)

7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a,3b,6,6-tetramethyl-1-(5-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}hex-4-en-1-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C52H86O22 (1062.561)

2-[(5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxy-2-{[2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]oxy}oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

2-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[2-(7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl)-6-methylhept-5-en-2-yl]oxy}oxane-3,4,5-triol

C53H90O21 (1062.5974)

(1s,3ar,3br,5as,7r,8r,9as,9bs,11r,11ar)-8,11-dihydroxy-7-{[(2s,3r,4s,5s)-5-hydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-3a,3b,6,6-tetramethyl-1-[(2s)-6-methyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept-5-en-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C52H86O22 (1062.561)

2-[(4-hydroxy-6-{[6-hydroxy-7,9,13-trimethyl-6-(4-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentyl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxy}-2-(hydroxymethyl)-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C52H86O22 (1062.561)

(1s,3ar,3br,5as,7s,9as,9bs,11ar)-1-[(2s,5s)-2,5-dihydroxy-6-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept-6-en-2-yl]-7-{[(2s,3r,4s,5s)-5-hydroxy-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-3a,3b,6,6-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C52H86O22 (1062.561)

4-({5-benzyl-6,13,16,21-tetrahydroxy-15-[(4-hydroxyphenyl)methyl]-2-isopropyl-4,11-dimethyl-3,9,22-trioxo-8-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl}-c-hydroxycarbonimidoyl)-2-({1-hydroxy-2-[(1-hydroxybutylidene)amino]-4-methylpentylidene}amino)butanoic acid

C54H78N8O14 (1062.5637)

7-[(5-{[5-({5-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-4-methoxy-6-methyloxan-2-yl}oxy)-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl)oxy]-3a,3b-dihydroxy-1-(1-hydroxyethyl)-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl benzoate

C56H86O19 (1062.5763)

2-({2-[(4,5-dihydroxy-2-{[14-hydroxy-15-(5-hydroxy-2,6,6-trimethyloxan-2-yl)-7,7,12,16-tetramethyl-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxan-3-yl)oxy]-4,5-dihydroxyoxan-3-yl}oxy)-6-methyloxane-3,4,5-triol

C52H86O22 (1062.561)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-2-{[(1s,2r,4s,5r,8r,10s,13r,14r,17s,18r,20s)-2-hydroxy-20-(hydroxymethyl)-4,5,9,9,13,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

(2s,3r,4s,5r,6r)-2-{[(2r,3r,4r,5r,6r)-6-{[(1r,3r,3ar,5as,7s,9as,9br,11ar)-3-hydroxy-1-[(2r,5e)-7-hydroxy-5-isopropylhept-5-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-{[(2s,3s,4r,5r)-3,5-dihydroxy-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)

n-[(1s)-1-{[(2s,5s,8s,11r,12s,15s,18s,21r)-2-benzyl-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-5-[(4-hydroxyphenyl)methyl]-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-4-methoxy-4-oxobutyl]octanimidic acid

C53H78N10O13 (1062.575)

(2r,3r,4s,5s,6r)-2-[(2r)-4-[(1s,2r,4r,6r,7s,8r,9s,12r,13r,16s)-16-{[(2r,3r,4s,5s,6r)-4-hydroxy-6-(hydroxymethyl)-3,5-bis({[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})oxan-2-yl]oxy}-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C52H86O22 (1062.561)